The biostimulants market witnessed significant growth over the last few years and is projected to register lucrative growth in the forecasted period. The major growth drivers are high-value crops and organic agriculture and growing natural method of organic farming. However, lack of awareness among farmers may limit growth. The products are expected to drive growth opportunities for players operating in the biostimulants market during the forecast period.
The key players operating in the global biopesticides market include Bayer (Germany), Koppert (Netherlands), BASF SE (Germany), Syngenta (Switzerland), UPL Ltd (India), IsagroSpA (Italy), Valent Biosciences Corp (US), Eastman Chemical Company (US), Isagro (Italy), and Valent Bioscience Corp (France). The market comprises tier-1 players along with some local players with diverse product portfolios. Companies such as Bayer (Germany), BASF SE (Germany), Syngenta (Switzerland), UPL Ltd (India), and Eastman Chemical Co. dominate the market due to brand reputation, product differentiation, financial stability, and strong distribution network. The players are focused on lowering their environmental footprint and investing in research and development along with strategic growth initiatives such as acquisitions and product launches to strengthen their market position and capture a large consumer base.
Threat Of New Entrants
The threat of new entrants in the biostimulants market is moderate, owing to the moderate capital investment required. The biostimulants industry includes a large number of domestic and international participants, thereby limiting the profitability of the industry. This may limit the entry of new participants in the industry. Additionally, the government promotes organic farming and provides subsidies for manufacturing organic crops, which will further lower the barriers for new market entrants.
Hence, the threat of new entrants in the global biostimulants market is expected to be moderate.
Bargaining Power of Suppliers
There are several raw material suppliers in the market; biostimulant manufacturers can easily switch between suppliers as the switching costs are relatively low. This lowers the bargaining power of suppliers. However, manufacturers tend to prefer certain suppliers as they require an uninterrupted supply of assured quality products. The growing adoption of this method by the market players is restricting the bargaining power of the suppliers in this market.
Hence, the bargaining power of suppliers in the global Biostimulants market is expected to be moderate.
Bargaining Power Of Buyers
Customers select their products based on price, reliability, and quality. The presence of a large number of manufacturers and the availability of several products are the major factors for the high bargaining power of buyers. Economical prices of products enabled buyers to easily switch from one manufacturer to another due to quality & service issues. However, innovation in products, such as the development of biostimulants, enabled manufacturers to enhance their brand name, thereby creating brand loyalty and lower buyer power.
Hence, the bargaining power of buyers in the global biostimulants market is expected to be moderate
Threat Of Substitutes
There is no direct substitute for biostimulants. However, there are chances of internal substitutions such as synthetic growth regulators. There is limited scope for external substitution in the global market.
Hence, the threat of substitutes in the global Biostimulants market is expected to be low..
Intensity Of Rivalry
The biostimulants industry is highly fragmented, with high competition among industry players. The presence of several large players with the ability to enhance their operations through vertical integration will further escalate industry rivalry. The diversification of the product portfolio from chemical stimulants to biostimulants is expected to further increase the industry rivalry.
The established players in the market are competing in terms of quality and price, thus making the industry competitive and reducing the profit potential for the existing firms. The key players invest in R&D to bring innovation to their product lines and prioritize product development to meet the changing consumer preferences.
Hence, the intensity of rivalry in the global biostimulants market is expected to be high.
